Compare WMK & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMK | OMCL |
|---|---|---|
| Founded | 1912 | 1992 |
| Country | United States | United States |
| Employees | N/A | 3580 |
| Industry | Food Chains | Computer Manufacturing |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 1994 | 2000 |
| Metric | WMK | OMCL |
|---|---|---|
| Price | $68.87 | $37.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $54.17 |
| AVG Volume (30 Days) | 106.9K | ★ 359.7K |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.65 | 0.04 |
| Revenue | ★ $4,714,573,000.00 | $787,309,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | N/A | $5.22 |
| P/E Ratio | ★ $19.50 | $902.63 |
| Revenue Growth | 0.01 | ★ 9.93 |
| 52 Week Low | $59.99 | $22.66 |
| 52 Week High | $90.23 | $51.84 |
| Indicator | WMK | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 47.37 | 54.73 |
| Support Level | $67.91 | $32.20 |
| Resistance Level | $70.31 | $37.51 |
| Average True Range (ATR) | 1.79 | 1.48 |
| MACD | -0.15 | 0.33 |
| Stochastic Oscillator | 24.30 | 64.65 |
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.